» Articles » PMID: 27999574

A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation During a Subsequent Successful Pregnancy

Overview
Journal Front Immunol
Date 2016 Dec 22
PMID 27999574
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Inherited paternal HLA antigens from the semi-allogeneic fetus may trigger maternal immune responses during pregnancy, leading to the production of child-specific HLA antibodies. The prevalence of these HLA antibodies increases with the number of successful pregnancies. In the present study, we investigated the effect of a single prior miscarriage on HLA antibody formation during a subsequent successful pregnancy. Women with a successful pregnancy with one or more prior miscarriages ( = 229) and women with a successful pregnancy without a prior miscarriage ( = 58), and their children were HLA typed. HLA antibody analyses were performed in these women to identify whether HLA antibodies were formed against mismatched HLA class-I antigens of the last child. The percentage of immunogenic antigens was significantly lower after a single successful pregnancy that was preceded by a single miscarriage ( = 18 women) compared to a successful pregnancy that was preceded by a first successful pregnancy ( = 62 women). Thus, our data suggest that a previous miscarriage has a different impact on child-specific HLA antibody formation during a subsequent successful pregnancy than a previous successful pregnancy. The lower immunogenicity in these women cannot be explained by reduced numbers of immunogenic B-cell and T-cell epitopes. In conclusion, our observations indicate that increasing gravidity is not related to an increased prevalence of HLA antibodies in a single successful pregnancy that was preceded by a single prior miscarriage.

Citing Articles

Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status.

Habets D, Al-Nasiry S, Nagelkerke S, Voorter C, Spaanderman M, Kuijpers T Sci Rep. 2023; 13(1):5232.

PMID: 36997584 PMC: 10063683. DOI: 10.1038/s41598-023-32156-9.


Epidemiology of Pregnancy Complications Through the Lens of Immunological Memory.

Gregory E, Liu J, Miller-Handley H, Kinder J, Way S Front Immunol. 2021; 12:693189.

PMID: 34248991 PMC: 8267465. DOI: 10.3389/fimmu.2021.693189.


Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.

Del Angel-Pablo A, Buendia-Roldan I, Mejia M, Perez-Rubio G, Nava-Quiroz K, Rojas-Serrano J Cells. 2020; 9(3).

PMID: 32168865 PMC: 7140697. DOI: 10.3390/cells9030691.

References
1.
Masson E, Vidal C, Deschamps M, Bongain S, Thevenin C, Dupont I . Incidence and risk factors of anti-HLA immunization after pregnancy. Hum Immunol. 2013; 74(8):946-51. DOI: 10.1016/j.humimm.2013.04.025. View

2.
Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen J, Mooney N . Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013; 369(13):1215-26. DOI: 10.1056/NEJMoa1302506. View

3.
Sato T, Fujimori K, Sato A, Ohto H . Microchimerism after induced or spontaneous abortion. Obstet Gynecol. 2008; 112(3):593-7. DOI: 10.1097/AOG.0b013e31818345da. View

4.
Bouma G, van Caubergh P, van Bree S, Witvliet M, van Rood J, Claas F . Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation. 1996; 62(5):672-8. DOI: 10.1097/00007890-199609150-00023. View

5.
Geneugelijk K, Thus K, Spierings E . Predicting alloreactivity in transplantation. J Immunol Res. 2014; 2014:159479. PMC: 4020392. DOI: 10.1155/2014/159479. View